Company
Zota Health Care Ltd
Headquarters: Surat, India
Employees: 321
Market Cap
₹20.26 Billion
INR as of Jan. 1, 2025
US$236.1 Million
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $113.24 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $76.33 B |
| Marinomed Biotech AG | $56.13 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.
Stocks & Indices
Zota Health Care Ltd has the following listings and related stock indices.
Stock: NSE: ZOTA wb_incandescent